FMP

FMP

Enter

IDXX - IDEXX Laboratories, ...

photo-url-https://images.financialmodelingprep.com/symbol/IDXX.png

IDEXX Laboratories, Inc.

IDXX

NASDAQ

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

431.65 USD

4.32 (1%)

Operating Data

Year

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

Revenue

90.19M

53.21M

43.58M

44.37M

46.8M

40.74M

35.46M

30.87M

26.87M

23.39M

Revenue %

-

-41.01

-18.1

1.81

5.48

-12.95

-12.95

-12.95

-12.95

Ebitda

-2.5M

-34.71M

-10M

-3.52M

-10.98M

-9.97M

-8.68M

-7.55M

-6.57M

-5.72M

Ebitda %

-2.77

-65.24

-22.94

-7.93

-23.47

-24.47

-24.47

-24.47

-24.47

Ebit

-3.08M

-35.48M

-12.49M

-5.65M

-12.8M

-11.31M

-9.85M

-8.57M

-7.46M

-6.5M

Ebit %

-3.41

-66.69

-28.66

-12.74

-27.36

-27.77

-27.77

-27.77

-27.77

Depreciation

582.05k

770.11k

2.5M

2.14M

1.82M

1.35M

1.17M

1.02M

888.06k

773.03k

Depreciation %

0.65

1.45

5.73

4.81

3.89

3.31

3.31

3.31

3.31

Balance Sheet

Year

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

Total Cash

36.28M

28.78M

29.73M

25.42M

16.09M

20.71M

18.03M

15.69M

13.66M

11.89M

Total Cash %

40.23

54.09

68.22

57.3

34.38

50.84

50.84

50.84

50.84

Receivables

74.72M

41.95M

25.28M

27.29M

19.18M

26.25M

22.85M

19.89M

17.31M

15.07M

Receivables %

82.85

78.84

58.02

61.52

40.98

64.44

64.44

64.44

64.44

Inventories

5.6M

2.12M

5.43M

13.76k

9.49k

1.85M

1.61M

1.4M

1.22M

1.06M

Inventories %

6.21

3.98

12.47

0.03

0.02

4.54

4.54

4.54

4.54

Payable

19.17M

8.89M

7.74M

7.36M

8.31M

7.34M

6.39M

5.56M

4.84M

4.21M

Payable %

21.25

16.71

17.76

16.58

17.75

18.01

18.01

18.01

18.01

Cap Ex

-657.03k

-323.29k

-299.9k

-227.81k

-742.6k

-336.04k

-292.52k

-254.63k

-221.64k

-192.93k

Cap Ex %

-0.73

-0.61

-0.69

-0.51

-1.59

-0.82

-0.82

-0.82

-0.82

Weighted Average Cost Of Capital

Price

3.58

Beta

Diluted Shares Outstanding

41.72M

Costof Debt

4.4

Tax Rate

After Tax Cost Of Debt

4.4

Risk Free Rate

Market Risk Premium

Cost Of Equity

Total Debt

6.29M

Total Equity

149.37M

Total Capital

155.66M

Debt Weighting

4.04

Equity Weighting

95.96

Wacc

7.3

Build Up Free Cash Flow

Year

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

Revenue

90.19M

53.21M

43.58M

44.37M

46.8M

40.74M

35.46M

30.87M

26.87M

23.39M

Ebitda

-2.5M

-34.71M

-10M

-3.52M

-10.98M

-9.97M

-8.68M

-7.55M

-6.57M

-5.72M

Ebit

-3.08M

-35.48M

-12.49M

-5.65M

-12.8M

-11.31M

-9.85M

-8.57M

-7.46M

-6.5M

Tax Rate

-0.77

-0.77

-0.77

-0.77

-0.77

-0.77

-0.77

-0.77

-0.77

-0.77

Ebiat

-13.25M

-35.97M

-12.51M

-5.39M

-12.9M

-11.21M

-9.76M

-8.49M

-7.39M

-6.44M

Depreciation

582.05k

770.11k

2.5M

2.14M

1.82M

1.35M

1.17M

1.02M

888.06k

773.03k

Receivables

74.72M

41.95M

25.28M

27.29M

19.18M

26.25M

22.85M

19.89M

17.31M

15.07M

Inventories

5.6M

2.12M

5.43M

13.76k

9.49k

1.85M

1.61M

1.4M

1.22M

1.06M

Payable

19.17M

8.89M

7.74M

7.36M

8.31M

7.34M

6.39M

5.56M

4.84M

4.21M

Cap Ex

-657.03k

-323.29k

-299.9k

-227.81k

-742.6k

-336.04k

-292.52k

-254.63k

-221.64k

-192.93k

Ufcf

-74.48M

-9.55M

1.89M

-457.01k

-2.76M

-20.08M

-6.19M

-5.39M

-4.69M

-4.08M

Wacc

7.3

7.3

7.3

7.3

7.3

Pv Ufcf

-18.72M

-5.38M

-4.36M

-3.54M

-2.87M

Sum Pv Ufcf

-34.86M

Terminal Value

Growth In Perpetuity Method

Long Term Growth Rate

Wacc

7.3

Free Cash Flow T1

-4.16M

Terminal Value

-78.54M

Present Terminal Value

-55.21M

Intrinsic Value

Enterprise Value

-90.07M

Net Debt

586.73k

Equity Value

-90.66M

Diluted Shares Outstanding

41.72M

Equity Value Per Share

-2.17

Projected DCF

-2.17 2.65%

DCF Levered

Download Excel

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep